<DOC>
	<DOCNO>NCT02284113</DOCNO>
	<brief_summary>This study evaluate iovera° device treat pain associate total knee arthroplasty ( TKA ) . This study also assess overall pain medication reduce follow TKA investigate relationship patient treat iovera° device length hospital stay , pain , patient satisfaction improve rehabilitation .</brief_summary>
	<brief_title>A Randomized , Study Evaluate Iovera° Device Treating Pain Associated With Total Knee Arthroplasty</brief_title>
	<detailed_description />
	<criteria>22 79 year age Scheduled undergo primary unilateral TKA spinal anesthesia primary diagnosis osteoarthritis American Society Anesthesiology ( ASA ) Physical Classification System class IIII Anticipation discharge home inpatient acute postop phase ( age , comorbidities , home environment , social support favor discharge home opinion Investigator ) Subject willing able give write informed consent . Subject fluent verbal write English . Subject willing able comply study instruction commit followup visit duration study . Subject good general health free systemic disease state physical condition might impair evaluation Investigator 's opinion , expose Subject unacceptable risk study participation . Exclusion Criteria Chronic opioid use ( defined daily almost daily use opioids &gt; 3 month ) . Concurrent painful physical condition , surgery , musculoskeletal disease require may require analgesic treatment study followup strictly relate target knee treat iovera° , potential confound postoperative assessment ( e.g. , significant pain joint , chronic neuropathic pain , concurrent plan contralateral TKA , concurrent foot , neck , spine , hip , musculoskeletal disease , arthritis , plan surgery , etc. ) . Greater 15° malalignment ( varus valgus ) preoperative radiograph . Previous myoscience FCT™ treatment . Previous Partial Total Knee Arthroplasty . Partial Total Knee Arthroplasty contralateral knee permit [ surgery complete least twelve ( 12 ) month prior screen ] . Body Mass Index ≥ 40 Prior surgery treatment area may alter anatomy infrapatellar branch saphenous nerve ( ISN ) anterior femoral cutaneous nerve ( AFCN ) result scar tissue treatment area . Any clot disorder and/or use anticoagulant ( e.g . warfarin , clopidogrel , etc . ) within seven ( 7 ) day prior administration device . Low dose aspirin ( 81mg less daily ) cardiac prophylaxis allow . Any local skin condition treatment sit Investigator 's opinion would adversely affect treatment outcome . Open and/or infect wound treatment area . Allergy lidocaine . History cryoglobulinemia History paroxysmal cold hemoglobinuria . History cold urticaria . History Raynaud 's disease . History opioid alcohol abuse . Subject pregnant planning become pregnant enrol study . Current enrollment investigational drug device study participation within 30 day prior screen . Currently treat related knee injury worker 's compensation claim equivalent ( i.e . legal case ) . Any chronic medical condition Investigator 's opinion would prevent adequate participation . Any chronic medication use ( prescription , overthecounter , etc . ) Investigator 's opinion would affect study participation Subject safety . For reason , opinion Investigator , Subject may suitable candidate study participation ( i.e. , history noncompliance , drug dependency , etc . ) .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>